awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q30587082-9EAC4415-C4AA-4064-9553-8DE049510E3C
Q30587082-9EAC4415-C4AA-4064-9553-8DE049510E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30587082-9EAC4415-C4AA-4064-9553-8DE049510E3C
Sorafenib dose escalation is not uniformly associated with blood pressure elevations in normotensive patients with advanced malignancies.
P2860
Q30587082-9EAC4415-C4AA-4064-9553-8DE049510E3C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q30587082-9EAC4415-C4AA-4064-9553-8DE049510E3C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94d61b6dfcff61c71e8c9d9739e8287d755892fc
P2860
Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors.